PFSA

PFSA

NASDAQ

Profusa, Inc. Common Stock

1.85

1.092(144.06%)
Volume

235.3M

Market Cap

$1.03M

P/E Ratio

-8.88

EPS

$-21.11


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

-8.88

P/B Ratio

-0.69

EPS

$-21.11

ROE

7.74%

Profit Margin

0.00%

Operating Margin

0.00%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
ACXP
Acurx Pharmaceuticals, Inc.
$3.54 -3.80% -0.67 $5.61M 0.00
ADIL
Adial Pharmaceuticals, Inc.
$1.75 3.55% -0.24 $1.68M 0.00
APRE
Aprea Therapeutics, Inc.
$0.70 -2.26% -0.43 $4.54M 0.00
BCDA
BioCardia, Inc.
$1.18 -1.67% -1.54 $6.84M 0.59
BFRI
Biofrontera Inc.
$0.99 1.03% -1.09 $11.53M 0.59
CHEK
Check-Cap Ltd.
$1.68 -11.11% -0.40 $9.83M -0.09
GBS
GBS Inc.
$0.47 -1.58% -0.22 $433,577 0.31
HCWB
HCW Biologics Inc.
$0.29 7.28% -0.03 $599,472 2.46
LUCY
Innovative Eyewear, Inc.
$1.08 1.89% -0.78 $4.31M 0.00
SBFM
Sunshine Biopharma, Inc.
$1.16 11.54% -0.81 $5.69M 0.00

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$412.50

52 Week Low

$0.41

Dividend

$0.00

Dividend Yield

0.00%

About Profusa, Inc. Common Stock

A digital-health company developing tissue-integrating biosensors (e.g. the Lumeeâ„¢ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemia